| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/12/2008 | US20080139453 Comprising an emulsifying crosslinked siloxane elastomer, a hydrophobically modified polymeric emulsifier, a solvent for the emulsifying crosslinked siloxane elastomer and water; for moisturizing, protecting and/or treating the skin and/or keratinous fibers; sunscreen |
| 06/12/2008 | US20080139450 Antimicrobial Compositions and Uses Thereof |
| 06/12/2008 | US20080138896 Methods for Inhibiting Melanocyte Stem Cell Loss |
| 06/12/2008 | US20080138791 Compositions and methods for prolonging survival of platelets |
| 06/12/2008 | US20080138444 Method For Treating Bronchoconstriction and Pulmonary Vaso-Constriction |
| 06/12/2008 | US20080138443 Carnitine-Containing Peritoneal Dialysis Solution Having Improved Biocompatibility |
| 06/12/2008 | US20080138442 Personal care method free of zinc pyrithione; basic zinc carbonate hydroxide, zinc copper carbonate, copper zinc carbonate hydroxide, phyllosilicate; anionic surfactant; skin, not scalp; treating microbial and fungal infections |
| 06/12/2008 | US20080138440 Methods of diagnosing and alleviating gadolinium toxicity |
| 06/12/2008 | US20080138437 Reduce toxicity while maintaining efficacy; mix with particulate hydroxyapatite as an auxiliary agent; alkylating agent, antimetabolite, an antitumor antibiotic, plant preparation, hormone preparation, immunotherapeutic agent, cisplatin; injection, infusion, oral administration |
| 06/12/2008 | US20080138436 Food Supplement Composition Suitable For Promoting Iron Absorption |
| 06/12/2008 | US20080138429 Coated Particles and Pharmaceutical Dosage Forms |
| 06/12/2008 | US20080138427 Reduced variation in the dissolution profile of a biologically active substance; pharmaceutical, drug sprayed while spraying a binding liquid to the cores; centrifugal fluidized bed coating granulation machine set to1.5 g/cm2 |
| 06/12/2008 | US20080138426 Remedies for sex hormone dependent disease |
| 06/12/2008 | US20080138425 Method for the Preparation of a Stable Lactate Metal Salt in Powder Form and Stable Metal Lactate Salt |
| 06/12/2008 | US20080138424 Fibrate particles having average particle size of less than 2000 nm; and a surface stabilizer; reduced fed/fasted variability |
| 06/12/2008 | US20080138423 Systems and methods for effecting cessation of tobacco use |
| 06/12/2008 | US20080138422 Analgesic agents, controlled release to provide a rapid onset of analgesic effect, also delayed and/or sustained release; amitriptyline, gabapentin; sleep disorders |
| 06/12/2008 | US20080138421 And a stabilizer of xylitol, sorbitol, polydextrose, isomalt, dextrose; gel matrix; urinary incontinence, urinary urge incontinence, imperative urinary urge, and/or increased urinary frequency |
| 06/12/2008 | US20080138416 Method and systems for using biopolymer-based beads and hydrogels |
| 06/12/2008 | US20080138413 N-benzyl-N-[3-(1H-indol-5-yl)-benzyl]-N',N'-dimethyl-ethane-1,2-diamine; sleep disorders |
| 06/12/2008 | US20080138412 Sustained release alfuzosin hydrochl formulation and method for their production |
| 06/12/2008 | US20080138411 Release rate controlling polymer, diluent, binder, lubricant,surfactant, solubilizing agent, bioavailability enhancer, acidifying agent; depression, depressive disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder |
| 06/12/2008 | US20080138409 Olanzapine pharmaceutical composition |
| 06/12/2008 | US20080138408 Drug delivery system and method |
| 06/12/2008 | US20080138406 Composition for treatment of pain in bones and joints |
| 06/12/2008 | US20080138404 Extended release formulations of carvedilol |
| 06/12/2008 | US20080138403 Pharmaceutical dosage forms of oxcarbazepine |
| 06/12/2008 | US20080138400 Curcumin analog or metabolite microencapsulated by a polyethylene glycolated liposome of dimyristoyl phosphatidylcholine, cholesterol, and dimyristoyl phsphatidylethanolamine; anticarcinogenic and antiproliferative agents; parenteral colloidal drug delivery system providing improved bioavailability |
| 06/12/2008 | US20080138399 Dual release nicotine formulations, and systems and methods for their use |
| 06/12/2008 | US20080138398 Dual release nicotine formulations, and systems and methods for their use |
| 06/12/2008 | US20080138397 Processes for taste-masking of inhaled formulations |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138394 Composite For Liver-Specific Delivery and Release of Therapeutic Nucleic Acids or Drugs |
| 06/12/2008 | US20080138391 Skin-friendly drug complexes for transdermal administration |
| 06/12/2008 | US20080138389 Contains a solvent-free matrix layer containing (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol; increased solubility |
| 06/12/2008 | US20080138388 Contains a basic drug (donepezil) having an octanol/water partition coefficient in the free state of 3 or above, a pressure-sensitive adhesive base and a methacrylic acid and methyl methacrylate |
| 06/12/2008 | US20080138383 Compositions and methods for treating seizures |
| 06/12/2008 | US20080138382 Biocompatible intraocular implants include a steroid and a polymer; biodegradable; eye implantable drug delivery systems; few or no negative side effects |
| 06/12/2008 | US20080138380 Use of Dermatan Sulfrates and/or Desulfated Heparins to Treat or Prevent Heparinoid-Induced Autoimmune Responses |
| 06/12/2008 | US20080138379 Preventing birth defects; administering formulation to women from preconception through first trimester of pregnancy |
| 06/12/2008 | US20080138375 Macrocyclic lactone compounds and methods for their use |
| 06/12/2008 | US20080138374 Molecular Plasma Deposition of Bioactive Small Molecules |
| 06/12/2008 | US20080138365 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138357 Vaccines Against Neisseria Meningitidis |
| 06/12/2008 | US20080138353 Alpha b-chrystallin as a therapy for inflammation |
| 06/12/2008 | US20080138351 Liposome treatment of viral infections |
| 06/12/2008 | US20080138350 Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery |
| 06/12/2008 | US20080138342 Using immunoglobulin specific to vascular endothelial growth factor receptor (Flt-1) as therapeutic tool in treatment toxemia in late pregnancy |
| 06/12/2008 | US20080138337 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138330 Methods and Compositions for Treating Conditions Involving Abnormal Angiogenesis |
| 06/12/2008 | US20080138329 Inhibitors of Dna Methylation in Tumor Cells |
| 06/12/2008 | US20080138328 Novel Use of the Kinases Rsk4 and Pak5 |
| 06/12/2008 | US20080138322 Pretreating with lipophilic substituted saccharide |
| 06/12/2008 | US20080138320 Method of using a probiotic agent for the treatment of diarrhea |
| 06/12/2008 | US20080138317 Monoglycerides; polyethers; antidiabetic agents; rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, asthma, acute respiratory distress syndrome, chronic obstructive pulmonary disease, and multiple sclerosis |
| 06/12/2008 | US20080138315 Using expression vector comprising UDP-glucuronosyltransferase (UGTIAI) as gene transfer tool in treatment of hyperbilirubinemia |
| 06/12/2008 | US20080138311 Allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet |
| 06/12/2008 | US20080138310 As wetting agents and polyquaternium" microbiocides; preferably ethylene oxide-1,2-butylene oxide copolymer |
| 06/12/2008 | US20080138297 2-(Cyclopent-3-enylmethyl)-tetrahydropyran derivatives; alkylation, esterification, acetalization; cosmetics, cleaning compounds, shampoo, mouthwashes, dentrifices, detergents, antiperspirants, dairy products, baked goods, air deodorizers, foods, drugs, wine, beer, tobacco, soups, ice cream, meats |
| 06/12/2008 | US20080138295 Administering cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide; side effect reduction from chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy; anticarcinogenic and antimetastasis agents; autoimmune diseases |
| 06/12/2008 | US20080138294 Drug delivery of a nicotine formulation in a single pulmonary dose; free of tobacco; multiple containers; aerosols, inhalants; may also administer an antidepressant or anxiolytic agent; smoking termination |
| 06/12/2008 | US20080138291 e.g. (4-Sulfamoylphenyl)thioureido fluorescein; bind to the enzyme under hypoxic conditions and are able to reverse the tumor acidification mediated by the enzyme; fluorescent dye for tumor detection by positron-emission tomography; antitumor, antiproliferative agent |
| 06/12/2008 | US20080138288 Combinations for treatment of neovasculature |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | DE202007007143U1 Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum Novel pharmaceutical composition for use as a laxative |
| 06/12/2008 | DE112006001619T5 Kristalline Base von Escitalopram und orodispersible Tabletten, die Escitalopram-Base umfassen The crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 06/12/2008 | DE102006058611A1 Use of active substances comprising glutamylamidoethylindol, kombucha, hypotaurine and/or ascorbic acid to prepare cosmetic composition for improving complexion radiance or for reducing cellular protein oxidation in keratinocytes |
| 06/12/2008 | DE102006058243A1 Pharmaceutical composition, useful prophylaxing and/or treating e.g. metabolic syndrome, diabetes mellitus, liver diseases, chronic-inflammatory diseases, rheumatic diseases, comprises a combination of pomegranate preparation and selenium |
| 06/12/2008 | DE102006058236A1 Indolizinderivate Indolizine derivatives |
| 06/12/2008 | DE102006057188A1 Celluloseether für Feststoffformulierungen Cellulose ethers for solid formulations |
| 06/12/2008 | DE102006055080A1 Use of clodronic acid as an active substance for producing a medicament in the form of an injectable solution or suspension for the treatment of navicular syndrome with an osteoporotic component in horses |
| 06/12/2008 | CA2823981A1 Film-coated preparation having improved stability |
| 06/12/2008 | CA2682596A1 Use of carboxyamidotriazole (cai) orotate in macular degeneration |
| 06/12/2008 | CA2672114A1 Use of epothilones in the treatment of osteoporosis and related diseases |
| 06/12/2008 | CA2672108A1 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 06/12/2008 | CA2672002A1 Cross-linked hyaluronic acid having long-lasting effect of treating arthritic disorders |
| 06/12/2008 | CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | CA2671987A1 Method for screening anti-cancer compounds inhibiting function of tm4sf5 and anti-cancer composition containing chalcone compounds |
| 06/12/2008 | CA2671975A1 Film-coated preparation having improved stability |
| 06/12/2008 | CA2671861A1 Urea and sulfamide derivatives as tafia inhibitors |
| 06/12/2008 | CA2671799A1 Cholesterylamines for the treatment and prevention of infectious diseases |
| 06/12/2008 | CA2671788A1 Chelating agent |
| 06/12/2008 | CA2671782A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/12/2008 | CA2671769A1 Treatment for dry eye |
| 06/12/2008 | CA2671749A1 Bicyclic compounds and uses as antidiabetics |
| 06/12/2008 | CA2671699A1 Thienyl-containing glycopyranosyl derivatives as antidiabetics |
| 06/12/2008 | CA2671698A1 Treatment for dry eye using testosterone and progestagen |
| 06/12/2008 | CA2671649A1 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors |
| 06/12/2008 | CA2671636A1 Pharmaceutical composition for external application and adhesive skin patch |
| 06/12/2008 | CA2671632A1 Novel protein kinase modulators and therapeutic uses thereof |
| 06/12/2008 | CA2671622A1 Treatment of cachexia |
| 06/12/2008 | CA2671615A1 Topical pharmaceutical composition |
| 06/12/2008 | CA2671614A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/12/2008 | CA2671613A1 Methods of use of trk receptor modulators |
| 06/12/2008 | CA2671543A1 Indazole compounds |